Document Detail


The contribution of Langerhans cells to cutaneous malignancy.
MedLine Citation:
PMID:  21071271     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
The skin is at the forefront of environmental exposures, such as ultraviolet radiation and a myriad of chemicals, and is at risk for malignant transformation. The skin is a highly responsive immunological organ that contains a unique population of immature intraepidermal dendritic cells (DCs) called Langerhans cells (LCs). Although LCs show morphological and migratory changes in response to epidermal perturbation, and can function as antigen-presenting cells to activate T cells, their role in carcinogenesis is unknown. Here we review recent studies that have provided clues to the potential roles that LCs might play in the pathogenesis of skin cancer, beyond their stimulation or regulation of adaptive immunity. Understanding this role of LCs might provide new perspectives on the relevance of DC populations that are resident within other epithelial tissues for cancer.
Authors:
Julia Lewis; Renata Filler; Debra A Smith; Kseniya Golubets; Michael Girardi
Publication Detail:
Type:  Journal Article     Date:  2010-11-09
Journal Detail:
Title:  Trends in immunology     Volume:  31     ISSN:  1471-4981     ISO Abbreviation:  Trends Immunol.     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100966032     Medline TA:  Trends Immunol     Country:  England    
Other Details:
Languages:  eng     Pagination:  460-6     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Ltd. All rights reserved.
Affiliation:
Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06511, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary...
Next Document:  Novel targets in M. tuberculosis: search for new drugs.